시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 리스테리아 모노사이토제네스 감염 치료 시장 보고서(2024년)
Listeria Monocytogenes Infections Treatment Global Market Report 2024
상품코드 : 1426215
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,000 ￦ 6,886,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,500 ￦ 10,329,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,000 ￦ 13,772,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

리스테리아 모노사이토제네스 감염증 치료제 시장 규모는 향후 몇 년동안 크게 성장할 것으로 예상됩니다. 2028년까지는 5.1%의 연평균 복합 성장률(CAGR)로 58억 6,000만 달러 규모에 달할 것으로 예상됩니다. 예측 기간 동안 예상되는 리스테리아 모노사이토제네스 감염 관리 증가는 식품 공급망의 세계화, 항균 치료의 지속적인 연구 개발 노력, 식습관 변화, 의료 분야의 국제 협력 증가, 감염성 질환에 대한 관심 증가 등 여러 요인과 관련이 있습니다. 관련이 있습니다.

리스테리아 모노사이토제네스 감염 치료제 시장은 식중독 증가로 인해 성장할 준비가 되어 있습니다. 오염된 음식이나 음료 섭취로 인해 발생하는 이러한 질병에는 리스테리아 모노사이토제네스 감염과 관련된 우려가 포함됩니다. 이러한 감염을 치료하면 위험을 줄이고 질병의 심각성을 줄일 수 있습니다. 특히 2022년 12월 유럽식품안전청은 2021년 식품으로 인한 사고가 전년 대비 29.8% 증가하여 약 4,005건을 기록했다고 보고했습니다. 이러한 증가는 식중독 발생률 증가가 리스테리아 모노사이토제네시스 감염증 치료제 시장의 성장에 매우 중요한 역할을 하고 있음을 보여줍니다.

정부 주도의 의료 연구 및 개발 이니셔티브는 리스테리아 모노사이토제네스 감염증 치료제 시장을 강화하는 것을 목표로 하고 있습니다. 이러한 노력에는 의료 문제를 해결하기 위한 정부 기관의 표적화된 행동, 정책 또는 자금 지원 프로그램이 포함됩니다. 특히 영국 정부가 2022년까지 의료 연구 및 제조에 2억 6,000만 파운드(미화 2억 7,065만 달러)를 투입하겠다는 약속은 이러한 노력의 증거입니다. 이 막대한 자금은 NHS 주도의 건강 연구, 진단 및 치료를 위한 프라이버시 보호 플랫폼, 생명과학 제조의 확장을 지원하는 것을 목표로 하고 있습니다. 이러한 정부의 지원은 리스테리아 모노사이토제네스 감염증 치료제 시장의 성장 궤도에 큰 영향을 미칠 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

제5장 세계 시장 규모와 성장

제6장 시장 세분화

제7장 지역 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 경쟁 벤치마킹

제32장 경쟁 대시보드

제33장 주요 인수합병(M&A)

제34장 향후 전망과 잠재성 분석

제35장 부록

LSH
영문 목차

영문목차

Treatment for Listeria monocytogenes infection involves medical interventions and therapeutic measures aimed at addressing and managing infections caused by this bacterium. Listeria monocytogenes is a pathogenic bacterium responsible for causing a serious illness called listeriosis in humans. This infection usually arises when individuals ingest contaminated food or beverages containing Listeria monocytogenes.

The main classes of drugs used for listeria monocytogenes infections treatment are Ampicillin, Gentamicin, Vancomycin, and others. Several types of infections include gastroenteritis, endocarditis, meningitis, bacteremia, and brain abscess. The drugs can be administered through various modes, such as oral, injectable, and other modes and are used by several end users, including hospitals, home care, specialty clinics, and others.

The listeria monocytogenes infections treatment market research report is one of a series of new reports from The Business Research Company that provides listeria monocytogenes infections treatment market statistics, including listeria monocytogenes infections treatment industry global market size, regional shares, competitors with a listeria monocytogenes infections treatment market share, detailed listeria monocytogenes infections treatment market segments, market trends and opportunities, and any further data you may need to thrive in the listeria monocytogenes infections treatment industry. This listeria monocytogenes infections treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The listeria monocytogenes infections treatment market size has grown strongly in recent years. It will grow from $4.52 billion in 2023 to $4.79 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. Historical growth in addressing Listeria monocytogenes infections was largely driven by factors such as the implementation of stricter food safety regulations, a rise in the frequency of foodborne illnesses, advancements in diagnostic methods, educational awareness programs, and improvements in healthcare infrastructure.

The listeria monocytogenes infections treatment market size is expected to see strongly grown in the next few years. It will grow to $5.86 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. Anticipated growth in managing Listeria monocytogenes infections in the forecast period is linked to several factors, including the globalization of food supply chains, ongoing research and development efforts in antimicrobial treatments, shifts in dietary patterns, increased international collaboration in healthcare, and a heightened focus on public health preparedness.

The listeria monocytogenes infection treatment market is poised for growth owing to the increasing prevalence of foodborne diseases. These illnesses, stemming from consuming contaminated food or beverages, encompass concerns related to listeria monocytogenes infections. The treatment for such infections mitigates risks and curbs the severity of the disease. Notably, in December 2022, the European Food Safety Authority reported a 29.8% surge in foodborne incidents, recording approximately 4,005 cases in 2021 compared to the previous year. This escalation underscores the pivotal role of the rising foodborne disease incidence in propelling the listeria monocytogenes infection treatment market.

Government-led initiatives in healthcare research and development are set to bolster the listeria monocytogenes infection treatment market. These initiatives encompass targeted actions, policies, or funding programs by government entities to address healthcare concerns. Notably, the UK government's commitment of £260 million (US $270.65 million) in 2022 towards healthcare research and manufacturing stands as a testament to this drive. This substantial funding aims to support NHS-led health research, privacy-preserving platforms for diagnostics and treatment, and the expansion of life sciences manufacturing. Such governmental backing significantly impacts the growth trajectory of the listeria monocytogenes infection treatment market.

The listeria monocytogenes infection treatment market is set to expand further owing to the escalating healthcare expenditure. This expenditure represents the cumulative spending on healthcare-related goods and services within an economy or healthcare system. The increased allocation of funds plays a pivotal role in fostering the development and accessibility of listeria monocytogenes infection treatment. For instance, in November 2022, healthcare expenditure in Canada surged to $331 billion, marking an increase of 0.8% from the previous year's 7.6%. This upward trend in healthcare expenditure significantly fuels the growth dynamics of the listeria monocytogenes infection treatment market.

Key companies in the listeria monocytogenes infection treatment market are prioritizing innovation, exemplified by products like Microgen Listeria-ID. This microbiological test, launched by Gold Standard Diagnostics in April 2023, enables the detection and confirmation of Listeria bacteria in food and environmental samples. Microgen Listeria-ID offers a comprehensive identification process, swiftly detecting and distinguishing Listeria spp species without additional materials. Renowned for its rapid and reliable identification, this test significantly expedites quality control measures and monitoring in food processing facilities, contributing to market revenue and efficiency.

In September 2022, Team Arnav Foundation, a US-based nonprofit group focused on finding treatment for juvenile sarcoma cancer, partnered with OS Therapies LLC. With this partnership, Team Arnav Foundation supports the phase IIb trial of OST-HER2 (Listeria monocytogenes) in recurrent, resected osteosarcoma. Additionally, Team Arnav's primary mission is to fund research that would lead to better treatments, higher cure rates, and reduced side effects for patients with malignant bone and soft tissue cancers. OS Therapies LLC is a US-based clinical-stage therapeutic company that develops immunotherapies based on live attenuated listeria monocytogenes (Lm) for solid tumors such as osteosarcoma.

Major companies operating in the listeria monocytogenes infections treatment market report are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Biogen Inc., Vertex Pharmaceuticals Incorporated, Fresenius Kabi AG, Aurobindo Pharma Ltd., Amneal Pharmaceuticals LLC, Lupin Ltd., ZydusCadila Health Care Ltd., Emergent Bio Solutions Inc., Wockhardt Ltd., Hainan Poly Pharm Co. Ltd., Novel Laboratories Inc., Bionpharma Inc., LimmaTech Biologics AG

North America was the largest region in the listeria monocytogenes infections treatment market in 2023. The regions covered in the listeria monocytogenes infections treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the listeria monocytogenes infections treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The listeria monocytogenes infections treatment market consists of revenues earned by entities by provide services such as diagnosis, antibiotic therapy, medical consultations, and nutritional support. The market value includes the value of related goods sold by the service provider or included within the service offering. The listeria monocytogenes infections treatment market also includes sales of penicillin G, meropenem, and trimethoprim-sulfamethoxazole (TMP-SMX). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Listeria Monocytogenes Infections Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on listeria monocytogenes infections treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for listeria monocytogenes infections treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The listeria monocytogenes infections treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Scope

Markets Covered:

Table of Contents

1. Executive Summary

2. Listeria Monocytogenes Infections Treatment Market Characteristics

3. Listeria Monocytogenes Infections Treatment Market Trends And Strategies

4. Listeria Monocytogenes Infections Treatment Market - Macro Economic Scenario

5. Global Listeria Monocytogenes Infections Treatment Market Size and Growth

6. Listeria Monocytogenes Infections Treatment Market Segmentation

7. Listeria Monocytogenes Infections Treatment Market Regional And Country Analysis

8. Asia-Pacific Listeria Monocytogenes Infections Treatment Market

9. China Listeria Monocytogenes Infections Treatment Market

10. India Listeria Monocytogenes Infections Treatment Market

11. Japan Listeria Monocytogenes Infections Treatment Market

12. Australia Listeria Monocytogenes Infections Treatment Market

13. Indonesia Listeria Monocytogenes Infections Treatment Market

14. South Korea Listeria Monocytogenes Infections Treatment Market

15. Western Europe Listeria Monocytogenes Infections Treatment Market

16. UK Listeria Monocytogenes Infections Treatment Market

17. Germany Listeria Monocytogenes Infections Treatment Market

18. France Listeria Monocytogenes Infections Treatment Market

19. Italy Listeria Monocytogenes Infections Treatment Market

20. Spain Listeria Monocytogenes Infections Treatment Market

21. Eastern Europe Listeria Monocytogenes Infections Treatment Market

22. Russia Listeria Monocytogenes Infections Treatment Market

23. North America Listeria Monocytogenes Infections Treatment Market

24. USA Listeria Monocytogenes Infections Treatment Market

25. Canada Listeria Monocytogenes Infections Treatment Market

26. South America Listeria Monocytogenes Infections Treatment Market

27. Brazil Listeria Monocytogenes Infections Treatment Market

28. Middle East Listeria Monocytogenes Infections Treatment Market

29. Africa Listeria Monocytogenes Infections Treatment Market

30. Listeria Monocytogenes Infections Treatment Market Competitive Landscape And Company Profiles

31. Global Listeria Monocytogenes Infections Treatment Market Competitive Benchmarking

32. Global Listeria Monocytogenes Infections Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Listeria Monocytogenes Infections Treatment Market

34. Listeria Monocytogenes Infections Treatment Market Future Outlook and Potential Analysis

35. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기